RNA structural biology of neurodegeneration: phase separation, phase transition and proteinopathy
The Journal of Biochemistry · 03.09.2026 · 180 (3) · 179-184
DOI: 10.1093/jb/mvag040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Biochemistry, online erschienen am 11.06.2026. Verfasst von Yasushi Yabuki und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Neurology, Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811,…. Hauptthemen laut MEDLINE: RNA, Neurodegenerative Diseases, Prion Proteins. Die Arbeit nennt 33 Literaturangaben. Gefördert von: The Inter-University Research Network for High Depth Omics, Institute of Molecular Embryology and Genetics, Kumamoto University, International Research Core for Stem Cell-based Developmental Medicine Encourage Project, Takeda Science Foundation.
Abstract (Originalsprache)
Neurodegenerative disorders, including Alzheimer’s disease and Parkinson’s disease, are becoming increasingly prevalent in super-ageing societies. However, the molecular mechanisms by which prion-like proteins undergo aberrant phase transition, aggregation and propagation during neurodegeneration remain incompletely understood. Although these proteins are capable of undergoing liquid–liquid phase separation (LLPS), followed by a sol–gel transition in vitro, the factors that govern their pathological phase transition in vivo remain largely elusive. Notably, many prion-like proteins also possess RNA-binding properties, and accumulating evidence indicates that RNA plays pivotal roles in regulating both LLPS and the subsequent transition to more solid-like states. In this review, we summarize recent advances in the RNA structural biology of neurodegeneration, with particular emphasis on RNA G-quadruplexes (rG4s) as pathological determinants and discuss emerging mechanisms by which RNA structures promote the phase transition and proteinopathy of prion-like proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genomic Neurology, Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan.
- Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-Honmachi, Chuo-ku, Kumamoto 862-0973, Japan.
ORCID-Profile: Yasushi Yabuki, Norifumi Shioda
Förderung
- The Inter-University Research Network for High Depth Omics, Institute of Molecular Embryology and Genetics, Kumamoto University
- International Research Core for Stem Cell-based Developmental Medicine Encourage Project
- Takeda Science Foundation
- the Astellas Foundation for Research on Metabolic Disorders
- the Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Narishige Neuroscience Research Foundation
- Kowa Life Science Foundation
- The Pharmacological Research Foundation, Tokyo
Zitieren
APA
Yabuki, Y., & Shioda, N. (2026). RNA structural biology of neurodegeneration: phase separation, phase transition and proteinopathy. The Journal of Biochemistry, 180(3), 179-184. https://doi.org/10.1093/jb/mvag040
Vancouver
Yabuki Y, Shioda N. RNA structural biology of neurodegeneration: phase separation, phase transition and proteinopathy. The Journal of Biochemistry. 2026;180(3):179-184. doi:10.1093/jb/mvag040
BibTeX
@article{Yabuki2026,
author = {Yabuki, Yasushi and Shioda, Norifumi},
title = {RNA structural biology of neurodegeneration: phase separation, phase transition and proteinopathy},
journal = {The Journal of Biochemistry},
year = {2026},
volume = {180},
number = {3},
pages = {179--184},
doi = {10.1093/jb/mvag040}
}
EUVIMED